Skip to main content

Advertisement

SpringerLink
Log in

Sexual dysfunction in 2014

Men enjoy a year of significant progress

  • Year in Review
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Male sexual medicine has continued to evolve and several publications related to premature ejaculation, lower urinary tract symptoms, Peyronie's disease and testosterone replacement therapy have provided new insights in these fields. Our understanding has been revolutionized by these studies and clinical management in male sexual dysfunction has improved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McMahon, C. G. et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J. Sex. Med. 5, 1590–1606 (2008).

    Article  Google Scholar 

  2. Serefoglu, E. C. et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J. Sex. Med. 11, 1423–1441 (2014).

    Article  Google Scholar 

  3. Roehrborn, C. G. et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J. Urol. 179, 616–621 (2008).

    Article  CAS  Google Scholar 

  4. Glina, S. et al. Sexual Function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-Month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. J. Sex. Med. http://dx.doi.org/10.1111/jsm.12714 (2014).

  5. Levine, L. A. et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with peyronie's disease: a phase 3 open-label study. J. Sex. Med. http://dx.doi.org/10.1111/jsm.12731 (2014).

  6. Vigen, R. et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310, 1829–1836 (2013).

    Article  CAS  Google Scholar 

  7. Carson, C. C. 3rd & Rosano, G. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J. Sex. Med. 9, 54–67 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, 97239-3098, OR, USA

    Theodore R. Saitz

  2. Department of Urology, Bagcilar Training & Research Hospital, Cinnah Caddesi 47, Ankara, 06680, Cankaya, Turkey

    Ege Can Serefoglu

Authors
  1. Theodore R. Saitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ege Can Serefoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ege Can Serefoglu.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saitz, T., Serefoglu, E. Men enjoy a year of significant progress. Nat Rev Urol 12, 73–74 (2015). https://doi.org/10.1038/nrurol.2014.357

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.357

  • Springer Nature Limited

Search

Navigation